Market Overview

Benzinga's Volume Movers

Share:
Related VRTX
Biogen And Gilead Sciences Catch The Eye Of Short Sellers
4 Biotechs Piper Jaffray Is Buying On The Pullback
26 Stocks For September 2015 (Seeking Alpha)
Related
TG Therapeutics: A Buy Worth $22
TG Therapeutics to Present Clinical Data on TG-1101 and TGR-1202 at the 20th Congress of the European Hematology Association and the 13th International Congress on Malignant Lymphoma

Vertex Pharmaceuticals (NASDAQ: VRTX) shares moved up 41.68% to $94.37. The volume of Vertex Pharmaceuticals shares traded was 2978% higher than normal. Vertex Pharma reported that its two phase 3 study of Lumacaftor in combination with ivacaftor met the primary endpoint.

TG Therapeutics (NASDAQ: TGTX) shares rose 6.91% to $10.36. The volume of TG Therapeutics shares traded was 442% higher than normal. TG Therapeutics completed a licensing agreement with Ligand Pharma (NASDAQ: LGND) to develop inhibitors of IRAK4.

Wix.com (NASDAQ: WIX) surged 6.87% to $18.99. The volume of Wix.com shares traded 333% higher than normal. Wix.com announced that it had surpassed 50 million registered users worldwide.

Voxeljet AG (NASDAQ: VJET) shares climbed 3.71% to $18.15. The volume of Voxeljet shares traded was 200% higher than normal. Voxeljet's trailing-twelve-month revenue is $16.39 million.

Posted-In: volume moversNews Intraday Update Markets Movers

 

Related Articles (LGND + TGTX)

Get Benzinga's Newsletters